SCHEMBL30740906

SCHEMBL30740906

CCN(CC)C(=O)/C(C#N)=C(\O)c1cc(O)c(O)c(C(=O)OC)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 7/20 0.62
COMT P21964 6/20 0.62
KDM4E B2RXH2 5/20 0.39
LMNA P02545 4/20 0.39
GAA P10253 2/20 0.39
POLB P06746 2/20 0.39
NFKB1 P19838 1/20 0.39
XDH P47989 1/20 0.39
GFER P55789 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
FUT7 Q11130 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.38
GLA P06280 2/20 0.38
MEN1 O00255 1/20 0.36
ABCC3 O15438 1/20 0.36
ABCC4 O15439 1/20 0.36
ABCB11 O95342 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31520157 1.00 FTO (0.62) FTOCOMTKDM4ELMNAGAA
SCHEMBL30740941 0.89 COMT (0.52) FTOCOMTKDM4ELMNAGAA
SCHEMBL31520161 0.89 COMT (0.52) FTOCOMTKDM4ELMNAGAA
SCHEMBL30740960 0.88 FTO (0.67) FTOCOMTKDM4ELMNAFUT7
SCHEMBL32669494 0.81 FTO (0.67) FTOCOMTLMNAALDH1A1MEN1
SCHEMBL32669637 0.79 FTO (0.65) FTOCOMTLMNAMEN1ABCC3
SCHEMBL32669560 0.78 FTO (0.64) FTOCOMTLMNAPOLBALDH1A1
SCHEMBL32669971 0.78 FTO (0.64) FTOCOMTLMNAMEN1ABCC3
SCHEMBL32669702 0.78 FTO (0.64) FTOCOMTKDM4ELMNAPOLB
SCHEMBL20100822 0.77 COMT (1.00) FTOCOMTLMNAMEN1ABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed
EP-4561975-A1 FTO INHIBITORS RPXDS Co., Ltd (CN) 2025-06-04 EP disclosed
CN-119546566-A FTO inhibitors 瑞璞鑫(苏州)生物科技有限公司 2025-02-28 CN disclosed
WO-2024022491-A1 FTO INHIBITORS RPXDS CO., LTD (CN) 2024-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885COMT 52/4885KDM4E 374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.